SecBot SecBot
SECBOTREPLAY Home › Report › KPTI

KPTI · Nasdaq delisting after Ch.11

Karyopharm Therapeutics Inc. · 8-K filed Nov 5, 2026 at 07:00 ET

At the news

BEARISHIMPACT 8/10

8-K filed Nov 5, 2026 at 07:00 ET

Karyopharm Therapeutics received a delisting notice from Nasdaq following its Chapter 11 bankruptcy filing on November 2, 2026. Nasdaq determined to delist the company's common stock based on public interest concerns, residual equity concerns, and compliance issues. The company will not appeal, trading will be suspended on Nasdaq at the open on November 11, 2026, and the stock is expected to move to OTC under symbol KPTIQ. The company's prepackaged Chapter 11 plan provides that holders of common stock and preferred stock will receive no distribution, implying a complete loss of equity value.

  • Company filed Chapter 11 bankruptcy petitions on November 2, 2026
  • Nasdaq notified company on November 4, 2026 of delisting determination under Listing Rules 5101, 5110(b) and IM-5101-1
  • Company will not appeal the delisting determination
  • Trading suspension on Nasdaq at the opening of business on November 11, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access